19 results
10-Q
2021 Q1
SANA
Sana Biotechnology Inc
5 May 21
Quarterly report
4:40pm
nature of our in vivo and ex vivo cell engineering and the fact that these are novel and emerging fields, there is an inherent scarcity
DRS/A
chu7vx
18 Dec 20
Draft registration statement (amended)
12:00am
S-1/A
llq4kzin
28 Jan 21
IPO registration (amended)
7:56am
S-1
l1opa
13 Jan 21
IPO registration
12:00am
DRS
vmm6h
10 Nov 20
Draft registration statement
12:00am
424B4
jm20du 1rb41
5 Feb 21
Prospectus supplement with pricing info
6:05am
10-K
onnlz2prgxzh
24 Mar 21
Annual report
4:22pm
- Prev
- 1
- Next